City
New York
1,742 announced deals involving New York, most recent first, with the firms that advised on each.
Most recent
SEARCH ALL 1,742 Hogan Lovells Cadwalader advises Civitas Capital Group in providing construction loan for InterContinental Orlando 3 Nov 2026
Latham & Watkins Advises Vistra on Completed Acquisition of Cogentrix Natural Gas Portfolio 3 Nov 2026
Latham & Watkins Advises Pelthos Therapeutics in Combination With Castle Creek Biosciences 3 Nov 2026
Latham Advises on Aspen Neuroscience’s US$140.6 Million IPO 3 Nov 2026
Latham & Watkins Advises on Bambusa Therapeutics’ Upsized US$168.9 Million IPO 3 Nov 2026
Latham & Watkins Advises DoorDash on US$17 Billion Acquisition of Instacart 3 Nov 2026
Latham Advises A. O. Smith on Definitive Agreement With CPE 3 Nov 2026
Latham & Watkins Advises Platinum Equity in Acquisition of Energy Distribution Partners 29 Oct 2026
Latham & Watkins Advises Triton on Sale of Trench to GE Vernova 29 Oct 2026
Latham Advises Jio Platforms on INR 301,876 Million (US$3.2 Billion) IPO 29 Oct 2026
Linklaters advises thyssenkrupp on the spin-off and listing of tk accelis 29 Oct 2026
DLA Piper advises underwriters in Strive’s US$630 million preferred stock initial public offering 28 Oct 2026
Clifford Chance advises CAF on A/B Loan to Pan American Energy, S.L., Sucursal Argentina 28 Oct 2026
Latham Advises CoStar Group in US$730 Million Acquisition of Vexcel 28 Oct 2026
Latham Advises Guidewire on Acquisition of hyperexponential 28 Oct 2026
Clifford Chance advises the underwriters on CAF’s US$2 billion notes offering 27 Oct 2026
Clifford Chance advises on MUFG’s inaugural Australian dollar AT1 issuance 27 Oct 2026
Latham Advises on Corxel Pharmaceuticals and Amanat Acquisition Corp.’s Business Combination Agreement to Create a Publicly Listed Obesity-Focused Biopharmaceutical Company 27 Oct 2026
Latham & Watkins Advises LSEG on US$3.535 Billion Acquisition of Octus 27 Oct 2026
Linklaters advises RENK on sale of Slide Bearings to Miba 27 Oct 2026
Linklaters advises QIAGEN on recommended voluntary all-cash public takeover offer by EQT 27 Oct 2026
Clifford Chance advises Luxinva on the voluntary public takeover offer of QIAGEN NV 22 Oct 2026
News Clifford Chance advises on MUFG’s inaugural Australian dollar AT1 issuance 22 Oct 2026
Latham Advises on Smith & Wesson’s Acquisition of Savage Arms 22 Oct 2026
Latham Advises HPS on Investment in SBTH Asia Holdings Pte. Ltd. 22 Oct 2026
Clifford Chance advises Aligned Climate Capital on ~US$387 million financing for 126 MW solar portfolio 21 Oct 2026
Latham & Watkins Advises Melange Capital Partners as Lead Investor in EnCap’s US$3.5 Billion Minerals Continuation Vehicle 21 Oct 2026
Latham & Watkins Advises Morgan Stanley Capital Partners on Acquisition of The Rapid Group 21 Oct 2026
Latham & Watkins Advises Trumid in US$1.97 Billion Acquisition by Tradeweb 21 Oct 2026
TriGemX Bio, a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and TCGX Acquisition Corp. (Nasdaq: TCGX), a special purpose acquisition company (SPAC) sponsored by TCGX, have announced the execution of a definitive business combination agreement that will result in TriGemX Bio becoming a publicly traded company. The combined company will be named TriGemX Bio, Inc. and is expected to trade on Nasdaq under the new ticker symbol TGEM. Latham & Watkins LLP represents TCGX in the transaction with a corporate team led by Houston partners Ryan Maierson and Ryan Lynch, with associates Taylor Allison, Cooper Shear, and Luisa Gomez Yokubaitis, with assistance from Zachary Mouton. Advice was also provided on tax matters by Houston partner Jared Grimley, with associates Dominick Constantino and Graham Core; on benefits matters by Los Angeles partner Michelle Carpenter, with associate Jordan Barnes; on healthcare regulatory matters by Washington, D.C. partner Nathan Beaton and counsel Nicole Liffrig Molife and Chad Jennings, with associate Margaret Rote; on funds matters by Chicago partner David Moore and New York partner Jennifer Tian;* on data cybersecurity matters by New York partner Jessica Cohen, with associates Laura Geraci and Nat Lewis; on data privacy and cybersecurity matters by Bay Area partner Heather Deixler, with associate Ryleigh Chen; on environmental matters by Los Angeles/Houston partner Joshua Marnitz, with associate Brandon Kerns; on anti-bribery and anti-money laundering matters by Washington, D.C. partner Daniel Dominguez, with associates Patricia Amselem Bensadon and Ai Ni Lim; on antitrust matters by Washington, D.C. partner Jason Cruise and Washington, D.C. counsel Ngoc Hulbig; and on economic sanctions and export controls matters by Washington, D.C. partner Eric Volkman, with associate Amulya Vadapalli. *Admitted to practice in Illinois only. 21 Oct 2026
Latham Advises The Sterling Group on Partnership With United Window & Door Manufacturing 21 Oct 2026
Mayer Brown advises BNR Power Investments B.V. on $430 million sale of interest in YPF Luz to YPF S.A. 19 Oct 2026
DLA Piper advises Hyundai Transys Georgia Powertrain on US$560 million expansion 19 Oct 2026
DLA Piper advises POSCO International on US$550 million agreement to acquire Chord’s Marcellus gas assets 19 Oct 2026
DLA Piper guides First Digital through De-SPAC business combination with KOYN 19 Oct 2026
DLA Piper guides on the acquisition of Wesbell Communications Holding Inc. 19 Oct 2026
Latham & Watkins Advises Zocdoc on Acquisition of Sohar Health 19 Oct 2026
Latham Advises on Select Water Solutions’ Upsized US$900 Million Senior Notes OfferingLatham Advises on Select Water Solutions’ Upsized US$900 Million Senior Notes Offering 19 Oct 2026
Latham & Watkins Advises RxSight on Collaboration With Alcon to Develop Adjustable PCIOLsLatham & Watkins Advises RxSight on Collaboration With Alcon to Develop Adjustable PCIOLs 19 Oct 2026
Latham & Watkins Advises The Knot Worldwide in Agreement Adding Zola to Global Brand Portfolio 19 Oct 2026
Linklaters Advises Qatar Investment Authority on American Express Global Business Travel’s $6.3bn Acquisition by Long Lake Management 19 Oct 2026
Latham & Watkins Advises Partners Group on Investment in Scanntech 14 Oct 2026
Latham & Watkins Advises Magnite on Successful Completion of Term Loan and Revolving Credit Facility Repricing 14 Oct 2026
Latham & Watkins Advises Ares Management Corporation on €1 Billion Capital Contribution to Plenitude 14 Oct 2026
Latham & Watkins Advises Initial Purchasers on €1 Billion High-Yield Bond Issuance by Guala Closures 14 Oct 2026
Hogan Lovells Cadwalader advises the Central America Bottling Corporation in a benchmark US$875 million notes offering and related cash tender offer 9 Oct 2026
Latham & Watkins Advises Stuut on US$52.5 Million Series B Financing 9 Oct 2026
Linklaters Advises Itaú on US$300 Million Financing for Fértil Pampa S.A.U. 9 Oct 2026
Hogan Lovells Cadwalader advises Rice University as it launches One Giant Leap Ventures, backing startups across the university ecosystem 8 Oct 2026
Clifford Chance advises Banconal on US$500 million A/B loan to finance SMEs and the agricultural sector in Panama 8 Oct 2026
Latham Advises on Vaxcyte’s Concurrent Public Offerings of Common Stock, Pre-Funded Warrants, and Convertible Senior Notes 8 Oct 2026
Latham & Watkins Advises The Sterling Group Foundation Fund on Acquisition of Slingmax Group 8 Oct 2026
Latham & Watkins Represents OIC on Credit Income Strategy Launch With Liberty Mutual Investments 8 Oct 2026
Latham & Watkins Advises Hg in US$5.1 Billion Sale of Gen II Fund Services to KKR 8 Oct 2026
Mayer Brown advises Prescient Security on the sale of a majority stake to SGS. 7 Oct 2026
Clifford Chance advises on US$480 million multi-jurisdictional senior unsecured financing for Alicorp 7 Oct 2026
Latham & Watkins Advises ECP on US$834 Million Continuation Vehicle for Next Wave Energy Partners 6 Oct 2026
Latham Advises Sovos on Acquisition of Flowie 6 Oct 2026
Latham & Watkins Advises Charlesbank in Completed Merger of Spectrotel and AireSpring 6 Oct 2026
Linklaters advises Lenzing AG on approximately €300m rights issue 6 Oct 2026